Oncology or orphan drug share in approved new active substances 2015-2021

Published by
Matej Mikulic,
Sep 7, 2023
This statistic depicts the percentage of orphan and oncology drugs released in Canada and select other developed countries that were new active substances (NAS) from 2015 to 2021. According to the data, in 2021, 42 percent of approved new active substances received an orphan drug designation.

Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

August 2023

Region

Worldwide

Survey time period

2015 to 2021

Supplementary notes

Includes drugs launched in: Canada, Belgium, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, the United Kingdom, and the United States.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Orphan drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Orphan drugs

Rare diseases

4

Market overview

5

Companies

4

Products

6

Research and development

6

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Orphan drugsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDiseases
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu